Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,849 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05657483 | Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study | unknown | — | 128 | University of Campania Luigi VanvitelliOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06366308 | Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population | unknown | — | 10,000 | West China HospitalOTHER | 0 | Apr 16, 2024 | clinicaltrials |
| NCT03700099 | Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide | unknown | Phase 2 | 30 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05748353 | Endocrine Disruptors and Life STILe in Breast Cancer Development(STILVARCA) | unknown | — | 275 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06363708 | Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer | unknown | N/A | 20 | Zhongnan HospitalOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06308406 | A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer | unknown | Phase 1 / Phase 2 | 54 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 11, 2024 | clinicaltrials |
| NCT04387500 | Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma | unknown | Phase 2 | 41 | West China HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05848648 | PPK Study Based on Quantitative Pharmacology in Patients With Pamipril | unknown | — | 50 | Qianfoshan HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06355076 | New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection | unknown | N/A | 94 | Qilu Hospital of Shandong UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05669443 | Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy | unknown | N/A | 42 | Gangnam Severance HospitalOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT06351228 | Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project(Eternity) | unknown | — | 400 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT02266745 | A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts | unknown | Phase 2 | 109 | Promontory Therapeutics Inc.INDUSTRY | 2 | Apr 5, 2024 | clinicaltrials |
| NCT05204199 | Role of Microbiome in BCG Responsiveness Prediction(SILENTEMPIRE) | unknown | — | 120 | Cédric PoyetOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT05123391 | Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer | unknown | N/A | 60 | Pontificia Universidad Catolica de ChileOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06347614 | Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study(Two-step RP) | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06344715 | Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC. | unknown | Phase 1 | 78 | SL VAXiGENINDUSTRY | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06241235 | Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma | unknown | Phase 1 / Phase 2 | 48 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06341855 | Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer | unknown | N/A | 100 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06342323 | The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy(ONFM-SBRT) | unknown | — | 57 | Peking University Third HospitalOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06103526 | Immunonutrition in ERAS Protocols in Gynecologic Oncology(NUTRIGO) | unknown | N/A | 200 | National and Kapodistrian University of AthensOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT06334406 | Antitumor T Cell Responses in Patients With Bladder Cancer(immunoBLAD) | unknown | — | 33 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Mar 28, 2024 | clinicaltrials |
| NCT05115812 | Renal Autotransplantation; Case Series | unknown | — | 30 | Methodist Health SystemOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT01851018 | Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment(HyBraFi) | unknown | N/A | 30 | CHU de Quebec-Universite LavalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05305820 | Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy(PANO) | unknown | N/A | 36 | Dublin City UniversityOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06322745 | Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy | unknown | N/A | 30 | Al-Azhar UniversityOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06324058 | Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC | unknown | N/A | 190 | Huashan HospitalOTHER | 0 | Mar 21, 2024 | clinicaltrials |
| NCT03795337 | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)(HYPOSTAT-II) | unknown | N/A | 475 | University Hospital Schleswig-HolsteinOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06317948 | Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)(MIKAPOCo) | unknown | — | 1,000 | IRCCS Ospedale San RaffaeleOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06320418 | The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression | unknown | — | 56 | Ain Shams UniversityOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06321640 | Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.(POSITive) | unknown | — | 265 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06317298 | Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy | unknown | N/A | 36 | Peking University First HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT06317610 | Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids | unknown | — | 100 | Chongqing University Cancer HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT04903873 | A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 110 | EutilexINDUSTRY | 2 | Mar 15, 2024 | clinicaltrials |
| NCT06242522 | Fertility and Pregnancy After Avelumab Treatment(FERTILAVE) | unknown | N/A | 50 | Hospices Civils de LyonOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06313775 | Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy | unknown | N/A | 18 | Sanpasitthiprasong HospitalOTHER_GOV | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06314113 | Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection(EGCG-HPV) | unknown | — | 50 | University of PalermoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06304922 | BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary | unknown | — | 45 | Assiut UniversityOTHER | 0 | Mar 12, 2024 | clinicaltrials |
| NCT06294886 | Vaginal Fluid Collection for Detection of Endometrial Cancer | unknown | — | 40 | Innovis LLCINDUSTRY | 1 | Mar 7, 2024 | clinicaltrials |
| NCT03549715 | NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma(NEMIO) | unknown | Phase 1 / Phase 2 | 121 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT03580109 | Spa Therapy for Upper or Lower Limb Lymphoedema(THERMOEDEME) | unknown | N/A | 160 | Association Francaise pour la Recherche ThermaleOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT04766320 | Study on TIL for the Treatment of r/r Gynecologic Tumors | unknown | Phase 1 | 15 | Shanghai 10th People's HospitalOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05472857 | Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression | unknown | Phase 1 | 30 | Suzhou Immunofoco Biotechnology Co., LtdINDUSTRY | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05910177 | Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin | unknown | Phase 2 | 30 | Fujian Cancer HospitalOTHER_GOV | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06294054 | Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy(SELECT) | unknown | — | 707 | University Hospital, RouenOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT04780217 | Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 42 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Mar 4, 2024 | clinicaltrials |
| NCT05710159 | The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients(iBLAD-app) | unknown | — | 100 | Odense University HospitalOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT05946161 | Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health | unknown | N/A | 30 | Universidade do PortoOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06284980 | Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study(TITANIUM) | unknown | — | 120 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 29, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 17, 2024source: clinicaltrials